| S8292 |
Selonsertib (GS-4997)
|
Selonsertib (GS-4997) is a highly selective and potent once-daily oral ASK1 inhibitor with potential anti-inflammatory, antineoplastic and anti-fibrotic activities.
|
-
Cell Metab, 2024, 36(11):2468-2488.e7
-
Cell Death Dis, 2024, 15(9):662
-
iScience, 2024, 27(8):110598
|
|
| S8289 |
NQDI-1
|
NQDI 1, an inhibitor of ASK1(apoptosis signal-regulating kinase 1), attenuates acute ischemic renal injury by modulating oxidative stress and cell death.
|
-
Redox Biol, 2023, 60:102618
-
J Neuroinflammation, 2023, 20(1):22
-
Mol Med Rep, 2023, 27(2)47
|
|
| S0067 |
GS-444217
|
GS-444217 (ASK1-IN-1) is a potent, selective, orally available and ATP-competitive inhibitor of ASK1 (apoptosis signal-regulating kinase 1) with IC50 of 2.87 nM.
|
|
|
| E2379 |
ASK1-IN-2
|
ASK1-IN-2 is a potent and orally active inhibitor of apoptosis signal-regulating kinase 1 (ASK1), with an IC50 of 32.8 nM.
|
|
|